Skip to main content

La Jolla Pharmaceutical Co

LJPCDelisted Aug 22, 2022
Industry
Biological Products, (No Diagnostic Substances)
SEC CIK
0000920465

La Jolla Pharmaceutical Co was delisted on Aug 22, 2022; its insiders filed their last Form 4 on Aug 24, 2022; 41 institutions reported holding it in 13F filings for Q2 2022, worth $53.9M in total; no superinvestor held it.

13F holders, Q4 2021

Institutional positions in La Jolla Pharmaceutical Co as of Dec 31, 2021. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works

Institutional holders
44
−10 vs. Q3 2021
Shares held
16.7M
−1.04M (−5.9%) vs. Q3 2021
Total value
$77.8M
+$6.89M (+9.7%) vs. Q3 2021
New holders
5
14 more added
Sold out
15
17 more reduced

Compare with Q3 2021: new holders, sold out and not filed yet

Holders and value by quarter

Institutions reporting LJPC on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.

Institutional holdersQ4 2021: 44 institutions
Q1 2021: 76 institutionsQ2 2021: 62 institutionsQ3 2021: 54 institutionsQ4 2021: 44 institutionsQ1 2022: 45 institutionsQ2 2022: 41 institutionsQ3 2022: 0 institutionsQ4 2022: 0 institutionsQ1 2023: 0 institutionsQ2 2023: 0 institutionsQ3 2023: 0 institutionsQ4 2023: 0 institutionsQ1 2024: 0 institutionsQ2 2024: 0 institutionsQ3 2024: 0 institutionsQ4 2024: 0 institutionsQ1 2025: 0 institutionsQ2 2025: 0 institutionsQ3 2025: 0 institutionsQ4 2025: 0 institutionsQ1 2026: 0 institutionsQ2 2026: 0 institutions
Value heldQ4 2021: $77.8M
Q1 2021: $88.2MQ2 2021: $78.6MQ3 2021: $70.9MQ4 2021: $77.8MQ1 2022: $70.4MQ2 2022: $53.9MQ3 2022: $0Q4 2022: $0Q1 2023: $0Q2 2023: $0Q3 2023: $0Q4 2023: $0Q1 2024: $0Q2 2024: $0Q3 2024: $0Q4 2024: $0Q1 2025: $0Q2 2025: $0Q3 2025: $0Q4 2025: $0Q1 2026: $0Q2 2026: $0
Institutions holding LJPC and their total value by quarter
QuarterHoldersValue
Q2 20260$0
Q1 20260$0
Q4 20250$0
Q3 20250$0
Q2 20250$0
Q1 20250$0
Q4 20240$0
Q3 20240$0
Q2 20240$0
Q1 20240$0
Q4 20230$0
Q3 20230$0
Q2 20230$0
Q1 20230$0
Q4 20220$0
Q3 20220$0
Q2 202241$53.9M
Q1 202245$70.4M
Q4 202144$77.8M
Q3 202154$70.9M
Q2 202162$78.6M
Q1 202176$88.2M

Institutions, Q4 2021

Shares, value and share of portfolio for each institution holding La Jolla Pharmaceutical Co; share changes are against Q3 2021.

Institutions holding LJPC in Q4 2021
InstitutionSharesValue% of portfolioChange in sharesAction
Tang Capital Management LLC9,607,934$44.7M8.99%−441,290−4.4%Reduced
RTW Investments, LP2,327,903$10.8M0.16%00.0%Unchanged
HealthInvest Partners AB830,000$3.86M5.44%+560,000+207.4%Added
Vanguard Group Inc829,443$3.86M0.00%−60,459−6.8%Reduced
D. E. Shaw & Co., Inc.588,802$2.74M0.00%−21,852−3.6%Reduced
Acadian Asset Management LLC435,387$2.02M0.01%+67,219+18.3%Added
BlackRock Inc.428,769$1.99M0.00%+3,452+0.8%Added
Geode Capital Management, LLC283,870$1.32M0.00%+8,454+3.1%Added
Tang Kevin C240,000$1.12M99.38%00.0%Unchanged
Millennium Management LLC139,501$649.0K0.00%−510−0.4%Reduced
Bank of New York Mellon Corp121,303$564.0K0.00%+51,809+74.6%Added
State Street Corp94,979$442.0K0.00%+1,500+1.6%Added
Globeflex Capital L P92,799$432.0K0.09%+65,710+242.6%Added
Two Sigma Investments, LP88,176$410.0K0.00%−28,918−24.7%Reduced
Hollencrest Capital Management82,355$383.0K0.03%+40,000+94.4%Added
Northern Trust Corp76,006$353.0K0.00%−1,833−2.4%Reduced
Morgan Stanley67,676$315.0K0.00%−38,818−36.5%Reduced
Citadel Advisors LLC61,977$288.0K0.00%+34,759+127.7%Added
Two Sigma Advisers, LP60,336$281.0K0.00%−66,023−52.3%Reduced
First Midwest Bank Trust Division41,731$194.0K0.02%00.0%Unchanged
Renaissance Technologies LLC35,500$165.0K0.00%−10,336−22.5%Reduced
Goldman Sachs Group Inc35,577$165.0K0.00%−8,545−19.4%Reduced
BNP Paribas Arbitrage, SA30,734$142.9K0.00%+30,535+15,344.2%Added
WealthTrust Axiom LLC25,400$118.0K0.04%00.0%Unchanged
Occudo Quantitative Strategies LP17,176$80.0K0.01%−712−4.0%Reduced
Schonfeld Strategic Advisors LLC15,700$73.0K0.00%00.0%Unchanged
Bank of America Corp14,156$66.0K0.00%−5,626−28.4%Reduced
Susquehanna International Group, LLP11,582$54.0K0.00%+11,582New
Tower Research Capital LLC (TRC)8,752$41.0K0.00%+3,420+64.1%Added
Group One Trading, L.P.8,127$38.0K0.00%+8,127New
The PNC Financial Services Group, Inc.7,000$33.0K0.00%00.0%Unchanged
Barclays PLC5,364$25.0K0.00%−2,340−30.4%Reduced
Wells Fargo & Company5,111$24.0K0.00%−500−8.9%Reduced
UBS Group AG4,427$21.0K0.00%+3,727+532.4%Added
Ellis Investment Partners, LLC2,800$13.0K0.00%00.0%Unchanged
Captrust Financial Advisors2,600$12.0K0.00%+2,600New
Simplex Trading, LLC2,088$9.00K0.00%+1,570+303.1%Added
JPMorgan Chase & Co1,551$7.00K0.00%+1,504+3,200.0%Added
Advisor Group Holdings, Inc.1,150$5.00K0.00%−1,350−54.0%Reduced
Amplius Wealth Advisors, LLC1,255$5.00K0.00%+1,255New
American Portfolios Advisors1,000$4.65K0.00%−500−33.3%Reduced
SOA Wealth Advisors, LLC.1,045$4.00K0.00%00.0%Unchanged
Tyler-Stone Wealth Management500$2.00K0.00%+500New
Royal Bank of Canada225$1.00K0.00%−50−18.2%Reduced
Boxer Capital, LLC0$00.00%−890,700−100.0%Sold out
Jacobs Levy Equity Management, Inc0$00.00%−158,455−100.0%Sold out
Ergoteles LLC0$00.00%−57,083−100.0%Sold out
HRT Financial LP0$00.00%−45,461−100.0%Sold out
Gsa Capital Partners LLP0$00.00%−26,143−100.0%Sold out
HighVista Strategies LLC0$00.00%−25,493−100.0%Sold out
Virtu Financial LLC0$00.00%−21,258−100.0%Sold out
Signaturefd, LLC0$00.00%−10,000−100.0%Sold out
Connor, Clark & Lunn Investment Management Ltd.0$00.00%−10,094−100.0%Sold out
Meeder Asset Management Inc0$00.00%−4,282−100.0%Sold out
FMR LLC0$00.00%−1,000−100.0%Sold out
Salem Investment Counselors Inc0$00.00%−850−100.0%Sold out
Nisa Investment Advisors, LLC0$00.00%−590−100.0%Sold out
Harbour Investments, Inc.0$00.00%−322−100.0%Sold out
Deutsche Bank AG0$00.00%−35−100.0%Sold out